Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors. Wang Y, Travers RJ, Farrell A, Lu Q, et al. PLoS One 2023;18:e0294438.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang Y, Travers RJ, Farrell A, Lu Q, et al. Differential vascular endothelial cell toxicity of established and novel BCR-ABL tyrosine kinase inhibitors. PLoS One 2023;18:e0294438.
PMID: 37983208